Richard J. (Hrsg.) Smith

Analysis of Drug Impurities

Buch

A key component of the overall quality of a pharmaceutical is control of impurities, as their presence, even in small amounts, may affect drug safety and efficacy. The identification and quantification of impurities to acceptable standards presents a significant challenge to the analytical chemist. Analytical science is developing rapidly and provides increasing opportunity to identify the structure, and therefore the origin and safety implications of these impurities, and the challenges of their measurement drives the development of modern quantitative methods. Written for both practicing and student analytical chemists, Analysis of Drug Imp… Mehr

CHF 259.00

Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)

Versandfertig innerhalb 1-3 Werktagen

V105: Folgt in ca. 15 Arbeitstagen

Produktdetails

Weitere Autoren: Webb, Michael L. (Hrsg.)

ISBN: 978-1-4051-3358-6
EAN: 9781405133586
Produktnummer: 2873648
Verlag: John Wiley and Sons Ltd
Sprache: Englisch
Erscheinungsjahr: 2007
Seitenangabe: 288 S.
Masse: H24.1 cm x B16.7 cm x D2.1 cm 660 g
Gewicht: 660
Sonstiges: Professional & Vocational

Über den Autor

Richard Smith is Director, Analytical Sciences at GlaxoSmithKline Research and Development, Tonbridge, UK and Michael Webb is Director, Analytical Sciences at GlaxoSmithKline Research and Development, Stevenage, UK. Contributors to the book: Dr Linda Ng Dr George Lunn Dr Patrick Faustino Dr Dave Elder Dr Mark R. Hadley Dr Peter Skett Dr Gary E. Martin Dr Ian Jones Dr Janet Hammond Dr Gerald Terfloth Dr Frank Cottee